RDHL RedHill Biopharma ADRs

RedHill Biopharma Ltd is a specialty biopharmaceutical company engaged in the development and commercialization of late clinical-stage, proprietary, and small molecule drugs for the treatment of gastrointestinal and inflammatory diseases and cancer. This is an ADR of a company whose stock trades outside of the U.S. as the symbol IT:RDHL.

$4.88  +0.06 (1.25%)
As of 09/17/2021 15:59:47 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  ADRs
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  Israel
Country of incorporation:  Israel
IPO date:  02/11/2013
Outstanding shares:  46,667,338
Average volume:  1,908,334
Market cap:   $224,936,569
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
CUSIP:    757468103
ISIN:        US7574681034
Sedol:      B96DLZ7
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy